We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Supporting Patient Activation in Transition to Home Intervention ([sPATH])

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02823795
Recruitment Status : Completed
First Posted : July 6, 2016
Last Update Posted : September 23, 2020
Sponsor:
Collaborators:
Vårdalstiftelsen
Forte
Information provided by (Responsible Party):
Mirjam Ekstedt, Karolinska Institutet

Tracking Information
First Submitted Date  ICMJE July 1, 2016
First Posted Date  ICMJE July 6, 2016
Last Update Posted Date September 23, 2020
Actual Study Start Date  ICMJE September 2016
Actual Primary Completion Date June 30, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: July 5, 2016)
Re-hospitalization [ Time Frame: 90 days ]
Registry data from the Swedish Register for Health Care Encounters
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: July 5, 2016)
  • Healthcare usage [ Time Frame: 30, 90 and 180 days ]
    Registry data from the Swedish Register for Health Care Encounters: re-hospitalization at 30 and 180 days. Emergency room and primary care visits at 30, 90 and 180 days
  • Medication adherence [ Time Frame: 30, 90 and 180 days ]
    Patient reported data using the Morisky Medication Adherence Scale, 8 items, and registry data using medicine data from the Swedish Prescribed Drug Registry
  • Patient activation [ Time Frame: 30, 90 and 180 days ]
    Patient reported data using the Patient Activation Measure, 13 item
  • Health related quality of life [ Time Frame: 30, 90 and 180 days ]
    Patient reported data using the EQ-5D-5L
  • Basic Psychological Needs [ Time Frame: 30, 90 and 180 days ]
    Patient reported data using the the Basic Psychological Need Satisfaction & Frustration Scale, 18 items
  • Depression [ Time Frame: 30, 90 and 180 days ]
    Patient reported data using PHQ-9 (Patient Health Questionnaire)
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE The Supporting Patient Activation in Transition to Home Intervention
Official Title  ICMJE The Supporting Patient Activation in Transition to Home (sPATH) Intervention - a Study Protocol of Randomized Controlled Trial
Brief Summary This study evaluates if motivational interviewing sessions aiming to motivate recently discharged patients with either chronic obstructive pulmonary disease or congestive heart failure to be active in post-discharge self-management can reduce re-hospitalization rates.
Detailed Description Included patients transition to home will be bridged through a telephone-call from a patient activation coach two days post-discharge. The patients will thereafter get motivational interviewing sessions by the same patient activation coach with the the goal that the patients are motivated to the knowledge, skills and confidence needed to manage the four main activity areas: 1) medication management; 2) adhere to care plan/ follow-up visits according to the discharge plan; 3) recognize indications (symptoms/signs) that the condition is worsening and how to respond; and 4) contact and manage relations/encounters with health care providers. Patients in control group will receive standard care, i.e. discharge and follow-up as in normal procedures. The investigators will use a randomization in permuted blocks of 10 intervention patients and 10 control patients included. To test the hypothesis that the re-hospitalizations rate is 15 % lower in the intervention group compared to the control group 242 patients (121 per group) are needed for power of 80% with the level of significance set to 5 % using two-sided chi-square.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Condition  ICMJE
  • Medication Adherence
  • Self-care
  • Heart Failure
  • Chronic Obstructive Pulmonary Disease
Intervention  ICMJE Behavioral: Motivational Interviewing
Patients will get motivational interviewing sessions by a patient activation coach (medical social workers and/or nurses trained in motivational interviewing and in the intervention) in five post hospital discharge sessions (whereof one face-to-face, four by phone) aiming to increase patient motivation to become active in self-management (medication management, care plan/follow-up, symptoms/signs of worsening condition, contacts with health care provider).
Study Arms  ICMJE
  • Experimental: sPATH
    Motivational Interviewing in five sessions post hospital discharge
    Intervention: Behavioral: Motivational Interviewing
  • No Intervention: Control
    Care as usual
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: September 20, 2020)
118
Original Estimated Enrollment  ICMJE
 (submitted: July 5, 2016)
400
Actual Study Completion Date  ICMJE September 2018
Actual Primary Completion Date June 30, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Patients aged 18 years or older with chronic obstructive pulmonary disease or congestive heart failure admitted at a short-term medical ward and who are living in their private home.

Exclusion Criteria:

  • Diagnoses of dementia or cognitive impairment, and need of interpreter to participate in conversations.

The exclusion criteria are related to the patients' possibilities to participate in the motivational interviewing sessions by phone.

Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Sweden
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02823795
Other Study ID Numbers  ICMJE C751231003
Dnr 2014-0026 ( Other Grant/Funding Number: Vårdalsstiftelsen )
Dnr 2014-4948 ( Other Grant/Funding Number: Forte )
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE
Plan to Share IPD: Undecided
Current Responsible Party Mirjam Ekstedt, Karolinska Institutet
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Karolinska Institutet
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE
  • Vårdalstiftelsen
  • Forte
Investigators  ICMJE
Principal Investigator: Mirjam Ekstedt, Professor LIME, Karolinska Institutet
PRS Account Karolinska Institutet
Verification Date September 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP